Tech firm MFine helps people monitor blood pressure, glucose on smartphones

MFine has democratised health care at home by bringing these solutions on to devices that are more ubiquitous and affordable than wearables

India is currently experiencing a massive increase in non-communicable diseases (NCDs) and bears a higher burden than most nations, particularly in cardiovascular and chronic respiratory diseases, hypertension and diabetes. There are more than 200 million diagnosed hypertension patients in the country who have limited access to BP (blood pressure) measuring tools for use at home. Similarly, there are over 80 million diabetes patients and 200 million pre-diabetic people in India who primarily monitor their glucose levels by using invasive and time-consuming blood tests. 

It is this problem that Bengaluru-based health tech firm platform MFine is addressing. The firm has built